BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 16681777)

  • 21. Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.
    Agarwal R; Alifrangis C; Everard J; Savage PM; Short D; Tidy J; Fisher RA; Sebire NJ; Harvey R; Hancock BW; Coleman RE; Seckl MJ
    J Reprod Med; 2014; 59(1-2):7-12. PubMed ID: 24597279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
    Barber EL; Schink JC; Lurain JR
    J Reprod Med; 2014; 59(5-6):199-203. PubMed ID: 24937957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
    Schmid P; Nagai Y; Agarwal R; Hancock B; Savage PM; Sebire NJ; Lindsay I; Wells M; Fisher RA; Short D; Newlands ES; Wischnewsky MB; Seckl MJ
    Lancet; 2009 Jul; 374(9683):48-55. PubMed ID: 19552948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally-aggressive gestational trophoblastic neoplasms.
    Cole LA
    Gynecol Oncol; 2012 Apr; 125(1):145-50. PubMed ID: 22198244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
    Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
    Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
    Gallion HH; van Nagell JR; Donaldson ES; Higgins RV
    Gynecol Oncol; 1989 Jul; 34(1):98-100. PubMed ID: 2544491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
    Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
    Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.
    Aydiner A; Keskin S; Berkman S; Bengisu E; Ilhan HR; Tas F; Topuz E
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):971-7. PubMed ID: 22358303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rare Case of Combined Choriocarcinoma and Placental Site Trophoblastic Tumor Presenting as Skin Lesion: A Case Report.
    Chatterjee T; Martial A; Settypalli S; Lindahl L
    Am J Case Rep; 2022 Jun; 23():e936451. PubMed ID: 35715940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
    Cyriac S; Rajendranath R; Sridevi V; Sagar TG
    J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience.
    El-Lamie IK; El Sayed HM; Badawie AG; Bayomi WA; El-Ghazaly HA; Khalaf-Allah AE; El-Mahallawy MN; El-Lamie KI
    Int J Gynecol Cancer; 2006; 16(2):866-74. PubMed ID: 16681775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically Related Choriocarcinoma Developing 5 Yr After a Complete Hydatidiform Mole and Simulating a Cornual Ectopic Pregnancy.
    Chau DB; Beavis AL; Ronnett BM; Jenson E; Gocke CD; Anderson J; Nickles Fader A; Stone R
    Int J Gynecol Pathol; 2020 Jul; 39(4):367-372. PubMed ID: 31033803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gestational trophoblastic neoplasia].
    Langmár Z; Németh M
    Orv Hetil; 2011 Dec; 152(49):1971-3. PubMed ID: 22106165
    [No Abstract]   [Full Text] [Related]  

  • 38. Fertility-sparing partial hysterectomy for gestational trophoblastic neoplasia: an analysis of 36 cases.
    Cheng B; Liu ZX; Zhou W; Qian JH
    J Reprod Med; 2014; 59(5-6):274-8. PubMed ID: 24937969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
    Faaborg L; Niemann I; Ostenfeld EB; Hansen ES; Sunde L; Lindegaard JC
    Acta Oncol; 2016; 55(2):234-9. PubMed ID: 26106854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.